Oncology Medical News about colorectal carcinoma cells;stem cell-like phenotype

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells
British Journal of Cancer, 07/02/09

Kirkland SC et al. - In a study to investigate the role of type I collagen in specifying the colorectal cancer (CRC) cell phenotype, these results indicate that type I collagen promotes expression of a stem cell-like phenotype in human CRC cells likely through α2β1 integrin.

Methods

The effect of type I collagen on morphology, localisation of cell–cell adhesion proteins, differentiation, and stem cell-like characteristics was examined in a panel of human CRC cell lines.

Results

Human CRC cells grown on type I collagen in serum-free medium show an epithelial–mesenchymal-like transition (EMT-like), assuming a more flattened less cohesive morphology.
Type I collagen downregulates E-cadherin and β-catenin at cell–cell junctions.
Type I collagen inhibits differentiation, increases clonogenicity, and promotes expression of stem cell markers CD133 and Bmi1.
Type I collagen effects were partially abrogated by a function-blocking antibody to α2 integrin.

<< Previous
Topoisomerase I expression correlates to response to neoadjuvant...

Next >>
Neoadjuvant chemotherapy followed by interval debulking surgery...